Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Anderlini

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
British Journal of Haematology|May 1, 1997
Collection of peripheral blood stem cells from normal donors 60 years of age or olderP Anderlini, D Przepiorka, J Lauppe, et al.
Bone Marrow Transplantation|September 1, 1994
Acanthamoeba meningoencephalitis after bone marrow transplantationP Anderlini, D Przepiorka, M Luna, et al.
Bone Marrow Transplantation|May 22, 2001
Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databasesP Anderlini, J D Rizzo, M L Nugent, et al.
Bone Marrow Transplantation|July 19, 2016
Severe hepatitis C reactivation as an early complication of hematopoietic cell transplantationN T Oliver, Y L Nieto, B Blechacz, et al.
Hematology/Oncology Clinics of North America|November 30, 1999
Allogeneic hematopoietic transplantation as adoptive immunotherapy. Induction of graft-versus-malignancy as primary therapyR Champlin, I Khouri, S Kornblau, et al.
Leukemia|April 1, 1996
Causes of initial remission induction failure in patients with acute myeloid leukemia and myelodysplastic syndromesP Anderlini, M Luna, H M Kantarjian, et al.
Bone Marrow Transplantation|July 4, 2001
Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantationR Champlin, I Khouri, P Anderlini, et al.
British Journal of Haematology|June 1, 1996
Duration of filgrastim mobilization and apheresis yield of CD34+ progenitor cells and lymphoid subsets in normal donors for allogeneic transplantationP Anderlini, D Przepiorka, Y Huh, et al.
Bone Marrow Transplantation|July 3, 2007
Treatment of donor graft failure with nonmyeloablative conditioning of fludarabine, antithymocyte globulin and a second allogeneic hematopoietic transplantationE Jabbour, G Rondon, P Anderlini, et al.
British Journal of Haematology|November 25, 2000
Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapyR Champlin, I Khouri, A Shimoni, et al.
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
British Journal of Haematology|May 1, 1997
Collection of peripheral blood stem cells from normal donors 60 years of age or olderP Anderlini, D Przepiorka, J Lauppe, et al.
Bone Marrow Transplantation|September 1, 1994
Acanthamoeba meningoencephalitis after bone marrow transplantationP Anderlini, D Przepiorka, M Luna, et al.
Bone Marrow Transplantation|May 22, 2001
Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databasesP Anderlini, J D Rizzo, M L Nugent, et al.
Bone Marrow Transplantation|July 19, 2016
Severe hepatitis C reactivation as an early complication of hematopoietic cell transplantationN T Oliver, Y L Nieto, B Blechacz, et al.
Hematology/Oncology Clinics of North America|November 30, 1999
Allogeneic hematopoietic transplantation as adoptive immunotherapy. Induction of graft-versus-malignancy as primary therapyR Champlin, I Khouri, S Kornblau, et al.
Leukemia|April 1, 1996
Causes of initial remission induction failure in patients with acute myeloid leukemia and myelodysplastic syndromesP Anderlini, M Luna, H M Kantarjian, et al.
Bone Marrow Transplantation|July 4, 2001
Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantationR Champlin, I Khouri, P Anderlini, et al.
British Journal of Haematology|June 1, 1996
Duration of filgrastim mobilization and apheresis yield of CD34+ progenitor cells and lymphoid subsets in normal donors for allogeneic transplantationP Anderlini, D Przepiorka, Y Huh, et al.
Bone Marrow Transplantation|July 3, 2007
Treatment of donor graft failure with nonmyeloablative conditioning of fludarabine, antithymocyte globulin and a second allogeneic hematopoietic transplantationE Jabbour, G Rondon, P Anderlini, et al.
British Journal of Haematology|November 25, 2000
Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapyR Champlin, I Khouri, A Shimoni, et al.
Pageof 9